XORTX Therapeutics (ANUA.F) Q4 2025 Earnings

15NovConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-0.36
-0.28
-0.2
-0.11

Details

Expected EPS
-0.1437535491
Actual EPS
-0.111839
Surprise EPS
0.03
Surprise Percent
+22.2%

Description

XORTX Therapeutics (ANUA.F) has reported earnings of -0.111839 per share for Q4 2025.

0 Comments

Share your thoughts